Rankings
▼
Calendar
DBVT
DBV Technologies S.A.
$495M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$27M
-1112.7% margin
Net Income
-$27M
-1114.2% margin
EPS (Diluted)
$-5.65
QoQ Revenue Growth
-2.5%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$20M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$406M
Total Liabilities
$46M
Stockholders' Equity
$359M
Cash & Equivalents
$357M
← FY 2016
All Quarters
Q3 2016 →
DBVT Q2 2016 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena